Medical Therapy for Pediatric Vascular Anomalies

Overview

Journal Semin Plast Surg

Specialty General Surgery

Date 2014 Jul 22

PMID 25045333

Citations 13

Authors

Judith F Margolin

Heather Mills Soni

Sheena Pimpalwar

Affiliations

Soon will be listed here.

Abstract

Vascular anomalies (VAs) comprise a large variety of individual diagnoses that in different phases of treatment require a diverse number of medical specialists to provide optimal care. Medical therapies include agents usually associated with cancer chemotherapy, such as vincristine, as well more immunomodulatory types of drugs, such as glucocorticoids and sirolimus. These immunomodulating drugs are being successfully applied in cases that are typically categorized as vascular tumors, including kaposiform hemangioendothelioma (KHE) and tufted angioma (TA), as well as some of the more invasive types of vascular malformations (i.e., microcystic lymphatic malformations and blue rubber bleb nevus syndrome (BRBNS). These therapies need to be combined with good supportive care, which often involves anticoagulation, antimicrobial prophylaxis, and comprehensive pain and symptom-relief strategies, as well as appropriate drug monitoring and management of side effects of medical treatment. The optimal care of these patients frequently involves close collaboration between surgeons, interventional and conventional radiologists, medical subspecialists, and nurses.

Citing Articles

Review of diagnosis, differential diagnosis, and management of retroperitoneal lymphangioma.

Hoang V, Nguyen M, Van H, Hoang D Jpn J Radiol. 2022; 41(3):283-301.

PMID: 36327088 DOI: 10.1007/s11604-022-01356-0.

Sirolimus treatment for neonate with blue rubber bleb nevus syndrome: A case report.

Yang S, Yang M, Yue X, Tou J World J Clin Cases. 2021; 9(23):6929-6934.

PMID: 34447844 PMC: 8362515. DOI: 10.12998/wjcc.v9.i23.6929.

Vascular lesions of the head and neck: an update on classification and imaging review.

Brahmbhatt A, Skalski K, Bhatt A Insights Imaging. 2020; 11(1):19.

PMID: 32034537 PMC: 7007481. DOI: 10.1186/s13244-019-0818-3.

Therapeutic effect of laser on pediatric oral soft tissue problems: a systematic literature review.

Khosraviani F, Ehsani S, Fathi M, Saberi-Demneh A Lasers Med Sci. 2019; 34(9):1735-1746.

PMID: 31309364 DOI: 10.1007/s10103-019-02834-0.

Efficacy of systemic sirolimus in the treatment of generalized lymphatic anomaly and Gorham-Stout disease.

Ricci K, Hammill A, Mobberley-Schuman P, Nelson S, Blatt J, Glade Bender J Pediatr Blood Cancer. 2019; 66(5):e27614.

PMID: 30672136 PMC: 6428616. DOI: 10.1002/pbc.27614.

References

Kollipara R, Dinneen L, Rentas K, Saettele M, Patel S, Rivard D . Current classification and terminology of pediatric vascular anomalies. AJR Am J Roentgenol. 2013; 201(5):1124-35. DOI: 10.2214/AJR.12.10517. View

McCarthy J, Goldberg M, Zimbler S . Orthopaedic dysfunction in the blue rubber-bleb nevus syndrome. J Bone Joint Surg Am. 1982; 64(2):280-3. View

Safi F, Gupta A, Adams D, Anandan V, McCormack F, Assaly R . Kaposiform lymphangiomatosis, a newly characterized vascular anomaly presenting with hemoptysis in an adult woman. Ann Am Thorac Soc. 2014; 11(1):92-5. DOI: 10.1513/AnnalsATS.201308-287BC. View

Tlougan B, Lee M, Drolet B, Frieden I, Adams D, Garzon M . Medical management of tumors associated with Kasabach-Merritt phenomenon: an expert survey. J Pediatr Hematol Oncol. 2013; 35(8):618-22. DOI: 10.1097/MPH.0b013e318298ae9e. View

Perez Botero J, Burns D, Thompson C, Pruthi R . Successful treatment with thalidomide of a patient with congenital factor V deficiency and factor V inhibitor with recurrent gastrointestinal bleeding from small bowel arteriovenous malformations. Haemophilia. 2012; 19(1):e59-61. DOI: 10.1111/hae.12066. View

Krishnappa A, Padmini J . Blue rubber bleb nevus syndrome. Indian J Pathol Microbiol. 2010; 53(1):168-70. DOI: 10.4103/0377-4929.59219. View

Yuksekkaya H, Ozbek O, Keser M, Toy H . Blue rubber bleb nevus syndrome: successful treatment with sirolimus. Pediatrics. 2012; 129(4):e1080-4. DOI: 10.1542/peds.2010-3611. View

Yang J, Chan A . Pediatric thrombophilia. Pediatr Clin North Am. 2013; 60(6):1443-62. DOI: 10.1016/j.pcl.2013.09.004. View

Starkey E, Shahidullah H . Propranolol for infantile haemangiomas: a review. Arch Dis Child. 2011; 96(9):890-3. DOI: 10.1136/adc.2010.208884. View

10.

Chiu Y, Drolet B, Blei F, Carcao M, Fangusaro J, Kelly M . Variable response to propranolol treatment of kaposiform hemangioendothelioma, tufted angioma, and Kasabach-Merritt phenomenon. Pediatr Blood Cancer. 2012; 59(5):934-8. PMC: 3528889. DOI: 10.1002/pbc.24103. View

11.

Hassanein A, Mulliken J, Fishman S, Greene A . Evaluation of terminology for vascular anomalies in current literature. Plast Reconstr Surg. 2011; 127(1):347-351. DOI: 10.1097/PRS.0b013e3181f95b83. View

12.

Ganesh R, Reddy M, Janakiraman L, Sathiyasekaran M . Blue rubber bleb nevus syndrome. Indian J Pediatr. 2013; 81(3):317-8. DOI: 10.1007/s12098-013-1312-4. View

13.

Tekes A, Koshy J, Kalayci T, Puttgen K, Cohen B, Redett R . S.E. Mitchell Vascular Anomalies Flow Chart (SEMVAFC): a visual pathway combining clinical and imaging findings for classification of soft-tissue vascular anomalies. Clin Radiol. 2014; 69(5):443-57. DOI: 10.1016/j.crad.2013.11.016. View

14.

Soltani A, Reinisch J . Algorithmic approach to the management of hemangiomas. J Craniofac Surg. 2011; 22(2):585-8. DOI: 10.1097/SCS.0b013e31820873ac. View

15.

Croteau S, Liang M, Kozakewich H, Alomari A, Fishman S, Mulliken J . Kaposiform hemangioendothelioma: atypical features and risks of Kasabach-Merritt phenomenon in 107 referrals. J Pediatr. 2012; 162(1):142-7. PMC: 3494787. DOI: 10.1016/j.jpeds.2012.06.044. View

16.

Iacobas I, Burrows P, Adams D, Sutton V, Hollier L, Chintagumpala M . Oral rapamycin in the treatment of patients with hamartoma syndromes and PTEN mutation. Pediatr Blood Cancer. 2011; 57(2):321-3. DOI: 10.1002/pbc.23098. View

17.

Vignot S, Faivre S, Aguirre D, Raymond E . mTOR-targeted therapy of cancer with rapamycin derivatives. Ann Oncol. 2005; 16(4):525-37. DOI: 10.1093/annonc/mdi113. View

18.

Vetter-Kauczok C, Strobel P, Brocker E, Becker J . Kaposiform hemangioendothelioma with distant lymphangiomatosis without an association to Kasabach-Merritt-Syndrome in a female adult!. Vasc Health Risk Manag. 2008; 4(1):263-6. PMC: 2464749. DOI: 10.2147/vhrm.2008.04.01.263. View

19.

McClain K, Kozinetz C . A phase II trial using thalidomide for Langerhans cell histiocytosis. Pediatr Blood Cancer. 2005; 48(1):44-9. DOI: 10.1002/pbc.20578. View

20.

Croteau S, Kozakewich H, Perez-Atayde A, Fishman S, Alomari A, Chaudry G . Kaposiform lymphangiomatosis: a distinct aggressive lymphatic anomaly. J Pediatr. 2013; 164(2):383-8. PMC: 3946828. DOI: 10.1016/j.jpeds.2013.10.013. View